FIVE PRIME THERAPEUTICS INC Human Resources Contracts & Agreements

40 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Non-Employee Director Compensation Policy, effective November 21, 2019
Compensation Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Executive Severance Benefit Plan and Summary Plan Description, effective November 20, 2019
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2020
Retention Letter Agreement by and between the company and Francis Sarena, dated as of January 15, 2020
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Retention Letter Agreement by and between the company and Helen Collins, dated as of January 15, 2020
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Retention Letter Agreement by and between the company and David V. Smith, dated as of January 15, 2020
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Separation Agreement by and between the company and Aron M. Knickerbocker, dated as of September 19, 2019
Separation Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Consulting Agreement by and between the company and Lewis T. Williams, effective as of April 1, 2019
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Amendment No. 1 to the Confidential Consulting Agreement by and between the company and FLG Partners, LLC, dated as of October 13, 2018.v
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Executive Severance Benefits Agreement by and between the company and David V. Smith, dated as of November 26, 2018
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Executive Severance Benefits Agreement by and between the company and Bryan Irving, dated as of September 5, 2017
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Confidential Consulting Agreement, by and between the company and FLG Partners, LLC, effective as of April 13, 2018
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2018
Consulting Agreement by and between the company and Marc Belsky effective as of April 7, 2018
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2018
Annual Bonus Plan, effective January 1, 2018
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Executive Severance Benefits Agreement by and between the company and Helen Collins, dated as of March 20, 2017
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2018
Amendment No. 1 to the 2013 Omnibus Incentive Plan
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Amendment No. 2 to the Executive Severance Benefits Agreement by and between the Company and Aron Knickerbocker, dated as of October 18, 2017
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Annual Bonus Plan
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Restricted Stock Agreement
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2017
Executive Severance Benefits Agreement
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2017
Amendment No. 1 to the Executive Severance Benefits Agreement
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Executive Severance Benefits Agreement
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2017
Executive Transition and Severance Benefits Agreement
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2016
Retention Award Agreement
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2015
Amendment No. 1 to the Executive Severance Benefits Agreement
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2014
EXECUTIVE SEVERANCE BENEFITS AGREEMENT
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2014
EXECUTIVE SEVERANCE BENEFITS AGREEMENT
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2014
Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Restricted Stock Agreement
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2014
FIVE PRIME THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2002 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Amendment No. 1 to the Executive Severance BenefitsAgreement
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
EXECUTIVE SEVERANCE BENEFITS AGREEMENT
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Amendment No. 1 to the Executive Severance BenefitsAgreement
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
EXECUTIVE SEVERANCE BENEFITS AGREEMENT
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
2007 EXECUTIVE SEVERANCE BENEFITS AGREEMENT
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
FIVE PRIME THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN NON-QUALIFIED OPTION AGREEMENT
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
FIVE PRIME THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
FIVE PRIME THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN TABLE OF CONTENTS
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Option Agreement (Incentive Stock Option or Nonstatutory Stock Option) Five Prime Therapeutics, Inc. 2010 Equity Incentive Plan
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
FIVE PRIME THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:OCTOBER 28, 2010 APPROVED BY THESTOCKHOLDERS: DECEMBER 9, 2010 TERMINATION DATE:OCTOBER...
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
FIVE PRIME THERAPEUTICS, INC. 2002 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCKOPTION)
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
FIVE PRIME THERAPEUTICS, INC. 2002 EQUITY INCENTIVE PLAN ADOPTED: MARCH 14, 2002 APPROVED BY STOCKHOLDERS: MARCH 14, 2002 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS ONMAY 21,...
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013